Export financials
R1 RCM (RCM)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

R1 RCM Cash Flow 2021-2008 | RCM
Brief overview of R1 RCM 's cash generation
The comparison covers five available annual reports between 2017 and 2021.
Operating cash flow reached $264.8 million versus $20.9 million initially. Growth of +1,167% at roughly 88.7% CAGR was robust.
Operating cash flow was positive in all five observations, adding repeatability to the cash profile.
Each unit of cumulative profit produced roughly 3.93x of operating cash flow. Earnings quality looks high.
Operating cash margin reached 18% versus 4.6% initially. Revenue converted into cash more effectively.
Conclusion
The indicators point to resilient cash flows at R1 RCM : receipts are repeatable and financial needs appear comfortably covered.
Annual Cash Flow R1 RCM
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
265 M | 61.8 M | 114 M | 18.3 M | 20.9 M | -86.9 M | - | - | - | - | 16.4 M | 32 M | 15.1 M | - |
Depreciation & Amortization |
77.5 M | 68.7 M | 55.7 M | 38.8 M | 16.3 M | 10.2 M | 8.5 M | 6.05 M | 6.82 M | 6.36 M | 4.86 M | 6.16 M | 3.92 M | - |
Accounts Payables |
17.7 M | 18.2 M | 20.2 M | 9.9 M | 7.2 M | 7.9 M | 5.31 M | 12.5 M | 4.25 M | 900 K | 1.26 M | 30.1 M | - | - |
Accounts Receivables |
131 M | 91.3 M | 52.3 M | 42.2 M | 8.2 M | 4 M | 10.2 M | 4.44 M | 24.6 M | 25.9 M | 17.1 M | 53.9 M | - | - |
All numbers in USD currency
Quarterly Cash Flow R1 RCM
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | 30.9 M | - | 219 M | 128 M | 46 M | - | 50.5 M | 45.3 M | 600 K | - | 43.3 M | 44 M | 71.1 M | - | -6 M | -21.1 M | -9.9 M | - | -4.3 M | -22.9 M | -27.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.8 M | 6.16 M | 14.5 M | - | 2.67 M | -28.5 M | -45.3 M |
Depreciation & Amortization |
- | - | - | 18.9 M | - | 56.8 M | 35.5 M | 17.9 M | - | 50.9 M | 33.6 M | 15.7 M | - | 39.9 M | 25.8 M | 12.9 M | - | 27.6 M | 13.4 M | 4.9 M | - | 4.5 M | 3.8 M | 3.2 M | - | 2.67 M | 2.36 M | 2.27 M | - | 2.74 M | 2.1 M | 1.72 M | - | 4.28 M | 2.88 M | 1.4 M | - | 5.23 M | 3.52 M | 1.75 M | - | 8.4 M | 5.08 M | 2.46 M | - | 6.28 M | 4.11 M | 2 M |
Accounts Payables |
- | - | - | 21 M | 17.7 M | 22.5 M | 21 M | 22.8 M | 18.2 M | 21.8 M | 24.2 M | 24.8 M | 20.2 M | 24.7 M | 18.4 M | 13.5 M | 9.9 M | 7.8 M | 14.6 M | 5 M | 7.2 M | 6.9 M | 6.8 M | 2.3 M | 7.9 M | 3.89 M | 3.74 M | 2.07 M | 5.31 M | 6.34 M | 10.2 M | 6.17 M | 12.5 M | 4.94 M | 6.25 M | 5.5 M | 4.25 M | 4.25 M | 4.25 M | 4.25 M | 900 K | 43.4 M | 35.6 M | 23.4 M | 1.26 M | 26.8 M | 30.3 M | 15.2 M |
Accounts Receivables |
- | - | - | 115 M | 131 M | 114 M | 96.8 M | 97.6 M | 91.3 M | 76.7 M | 64.3 M | 57.6 M | 52.3 M | 39.6 M | 42.7 M | 40.8 M | 42.2 M | 40.2 M | 40.9 M | 8 M | 8.2 M | 7.7 M | 7.2 M | 9 M | 4 M | 8.9 M | 6.58 M | 8.91 M | 10.2 M | 5.14 M | 3.38 M | 4.53 M | 4.44 M | 8.54 M | 13.5 M | 14.3 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 25.9 M | 137 M | 125 M | 111 M | 17.1 M | 107 M | 92 M | 94.1 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company R1 RCM , reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Health information services sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
American Well Corporation
AMWL
|
$ 12.72 | 2.66 % | $ 204 M | ||
|
Evolent Health
EVH
|
$ 3.61 | 4.34 % | $ 412 M | ||
|
GoodRx Holdings
GDRX
|
$ 3.36 | 2.44 % | $ 1.2 B | ||
|
Health Catalyst
HCAT
|
$ 1.76 | 0.57 % | $ 123 M | ||
|
HealthEquity
HQY
|
$ 91.55 | 1.68 % | $ 7.89 B | ||
|
HealthStream
HSTM
|
$ 31.54 | 2.34 % | $ 947 M | ||
|
Omnicell
OMCL
|
$ 34.64 | 3.1 % | $ 1.59 B | ||
|
OptimizeRx Corporation
OPRX
|
$ 8.72 | 1.75 % | $ 162 M | ||
|
Progyny
PGNY
|
$ 25.86 | 2.5 % | $ 2.2 B | ||
|
Phreesia
PHR
|
$ 10.37 | 2.88 % | $ 619 M | ||
|
Schrödinger
SDGR
|
$ 32.6 | 7.56 % | $ 2.39 B | ||
|
So-Young International
SY
|
$ 2.74 | 0.36 % | $ 213 M | ||
|
Teladoc Health
TDOC
|
$ 5.79 | 4.89 % | $ 1.02 B | ||
|
10x Genomics
TXG
|
$ 97.74 | 4.53 % | $ 12.2 B | ||
|
Veeva Systems
VEEV
|
$ 283.45 | 3.7 % | $ 46.4 B | ||
|
Zhongchao
ZCMD
|
$ 1.91 | 3.24 % | $ 6.53 M | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | ||
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | ||
|
SCWorx Corp.
WORX
|
- | - | $ 7.71 M |